Improved standardised procedures. Improved sensitivity Letting us know they're now into the nitty gritty of voltage biases and the whole transistor development , like the 12CQ Expanded to the US as well, great news.
All in my opinion and I am less familiar with the gFET,
This is now starting to look like progress. Have to just get these testing processes done. Tweaks are less complex than what has to happen with the 12CQ
The market for the biochip is a more targeted one. Less necessity to look for scaling opportunities with big foundries.
We could well see some action here this year in terms of actual testing with bio samples.
AXE Price at posting:
30.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)